People with HIV are changing their regimens twice as often as a decade ago which may reflect the availability of safer options and the possibility of tailoring regimens to people’s individual needs. At the 19th European AIDS Conference (EACS 2023) in Warsaw, Dr Nicklas Brown of the Chelsea & Westminster Hospital in London highlighted that the most encountered reason for treatment change was drug intolerance, while the least frequent reason was treatment failure. The researchers also calculated toxicity switch rates for each drug, showing vast differences between drugs.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
-
[Press release] FDA grants priority review of New Drug Application for Gilead’s once-daily HIV treatment of bictegravir plus lenacapavir
-
[CROI 2026] HIV i-Base: Investigational HIV combinations – daily, weekly, 4- and 6-monthly…
-
[Press release] FDA approves Merck’s once-daily IDVYNSO™ (doravirine/islatravir)
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.